Neurocrine biosciences appoints jude onyia, ph.d., as chief scientific officer

San diego, nov. 30, 2021 /prnewswire/ -- neurocrine biosciences, inc. (nasdaq: nbix) announced today that jude onyia, ph.d., has joined the company's executive management team as chief scientific officer.

NBIX Ratings Summary

NBIX Quant Ranking